This month 20 products from the popular ZYN brand became the first such pouches to be “authorized” by the U.S. Food and Drug Administration. While this falls short of the FDA’s designation ...

The United States Food and Drug Administration (FDA) has approved the marketing of ZYN nicotine pouch products after an extensive review certifies that the products meet public health standards.

In a statement published Jan. 16, the agency stated that 20 different Zyn nicotine pouch products can now be marketed to adults ages 21 and over.That doesn't mean the pouches are now "FDA approved ...

The U.S. Food and Drug Administration (FDA) has authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application (PMTA) pathway following an extensive ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco ...

WASHINGTON (AP) — Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes.

“The FDA’s decision recognizes the role that ZYN can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products.” ZYN has been ...

Unlike traditional cigarettes and smokeless tobacco products, Zyn pouches don’t contain the harmful carcinogens often linked to serious health conditions like cancer. In fact, studies suggest that ...

USA. The US Food and Drug Administration (FDA) today authorised Swedish Match’s ZYN nicotine pouches, marking a milestone for the Philip Morris International (PMI) subsidiary. ZYN is the first ...